Vol. 56 No. 2 (2022)

Radiology

Radiomic features as biomarkers of soft tissue pediatric sarcomas: preliminary results of a PET/MR study. Radiomics in pediatric oncology

Chiara Giraudo, Giulia Fichera, Roberto Stramare, Gianni Bisogno, Raffaella Motta, Laura Evangelista, Diego Cecchin, Pietro Zucchetta

138-141
- PDF
Evaluation of Toxic Effects of Chemotherapy in Lung Malignancies on Cerebral White Matter Using Diffusion Tensor Imaging

Sinem Aydın, Tarik Demir, Haci Mehmet Turk, Dilek Hacer Cesme, Altay Aliyev, Mehmet Ali Gultekin, Temel Fatih Yilmaz, Alpay Alkan

150-155
- PDF
SINGLE CENTER EXPERIENCE WITH EXCLUDER STENT GRAFT; 17 YEAR OUTCOME

Žiga Snoj, Tjasa Tomazin, Vladka Salapura, Dimitrij Kuhelj

156-163
- PDF

Nuclear medicine

Image reconstruction using small-voxel size improves image quality for positron emission tomography Small-voxel reconstruction in positron emission tomography

Sebastijan Rep, Petra Tomše, Luka Jensterle, Leon Jarabek , Katja Zaletel, Luka Ležaić

142-149
- PDF

Experimental oncology

Sunitinib potentiates the cytotoxic effect of electrochemotherapy in pancreatic carcinoma cells

Maja Cemazar, Tanja Jesenko, Masa Bosnjak, Bostjan Markelc, Anja Cerovsek, Gregor Sersa

164-172
- PDF
Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity

Vesna Todorovic, Blaz Groselj, Maja Čemažar, Ajda Prevc, Martina Nikšić Žakelj, Primož Strojan, Gregor Serša

173-184
- PDF
Co-treatment with Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer ALK5 inhibitor suppressed radiation induced metastasis

Yhunyhong Sheen, Ilyoung Cho, Jiwon Choi, Jiyoung Park

185-197
- PDF

Clinical oncology

Various clinical presentations of uveitis associated with durvalumab

Nika Vrabic, Ana Fakin, Polona Jaki Mekjavič, Urška Janžič, Martina Vrankar, Nataša VIdovič Valentinčič

129-137
- PDF
Residual disease in lymph nodes has no influence on survival in patients with incidental gallbladder cancer – institution experience with literature review

Assist. Mihajlo Đokić, M. D., PhD., general surgeon, Urban Stupan, Assist. Prof. Sabina Ličen, PhD., RN, MSN, Assist. Prof. Blaž Trotovšek, M. D., PhD., general and abdominal surgeon

208-215
- PDF
Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: Long-term outcomes of a phase I-II trial

Di Cui, Lei Du, Wei Yu, Boning Cai, Lingling Meng, Jun Yang, Yanrong Luo, Jing Chen, Lin Ma

216-227
- PDF
Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy PFS, PPS, and OS in NSCLC patients after chemoradiotherapy

Hisao Imai, Daijiro Kobayashi, Kyoichi Kaira, Sayaka Kawashima, Ken Masubuchi, Masumi Murata, Takeshi Ebara, Yoshizumi Kitamoto, Koichi Minato

228-237
Ribociclib plus letrozole in patients with hormone receptor‐positive, HER2‐negative advanced breast cancer with no prior endocrine therapy: subgroup analysis from the phase 3b CompLEEment‐1 trial Subgroup analysis of the CompLEEment‐1 trial

Simona Borstnar, Marketa Palacova, Aleksandra Łacko, Costanta Timcheva, Einav Nili Gal-Yam, Konstantinos Papazisis, Juraj Beniak, Pavol Kudela, Gábor Rubovszky

238-247
- PDF

Medical Physics

The Dose Accumulation and the Impact of Deformable Image Registration on Dose Reporting Parameters in a Moving Patient undergoing Proton Radiotherapy

Gašper Razdevšek, Urban Simončič, Luka Snoj, Andrej Studen

248-258
- PDF
Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer.

Dorota Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki

259-266
- PDF

Special communication

Cervix-Online computer program: 27 years of clinical registry for cervical cancer at the University Medical Centre Maribor

Iztok Takač, Vida Gavrić Lovrec, Darja Arko

198-207
- PDF

Radiology

Radiomic features as biomarkers of soft tissue pediatric sarcomas: preliminary results of a PET/MR study. Radiomics in pediatric oncology

Evaluation of Toxic Effects of Chemotherapy in Lung Malignancies on Cerebral White Matter Using Diffusion Tensor Imaging

SINGLE CENTER EXPERIENCE WITH EXCLUDER STENT GRAFT; 17 YEAR OUTCOME

Nuclear medicine

Image reconstruction using small-voxel size improves image quality for positron emission tomography Small-voxel reconstruction in positron emission tomography

Experimental oncology

Sunitinib potentiates the cytotoxic effect of electrochemotherapy in pancreatic carcinoma cells

Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity

Co-treatment with Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer ALK5 inhibitor suppressed radiation induced metastasis

Clinical oncology

Various clinical presentations of uveitis associated with durvalumab

Residual disease in lymph nodes has no influence on survival in patients with incidental gallbladder cancer – institution experience with literature review

Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: Long-term outcomes of a phase I-II trial

Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy PFS, PPS, and OS in NSCLC patients after chemoradiotherapy

Ribociclib plus letrozole in patients with hormone receptor‐positive, HER2‐negative advanced breast cancer with no prior endocrine therapy: subgroup analysis from the phase 3b CompLEEment‐1 trial Subgroup analysis of the CompLEEment‐1 trial

Medical Physics

The Dose Accumulation and the Impact of Deformable Image Registration on Dose Reporting Parameters in a Moving Patient undergoing Proton Radiotherapy

Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer.

Special communication

Cervix-Online computer program: 27 years of clinical registry for cervical cancer at the University Medical Centre Maribor

Make a Submission

Information

Follow us